Gadolinium-primarily based distinction agents (GBCAs) are widely Employed in magnetic resonance imaging (MRI) to reinforce the visibility of blood vessels, tumors, inflammation, and other inside structures. While frequently viewed as Safe and sound, considerations about GBCA toxicity have emerged in the last two decades—significantly in sufferers